Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding ...

Aug 27, 2024 · Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity

CouponFollow Extension

50%
OFF

Lilly Releases Zepbound® (tirzepatide) Single-dose Vials, Expanding ...

4 days from now

Aug 27, 2024 · Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity

lilly.com

50%
OFF

Lilly Introduces Single-Dose Vials Of Zepbound, Expanding Access …

4 days from now

Aug 27, 2024 · The new vials of Zepbound are available through a new self-pay pharmacy channel, priced over 50% lower than other incretin medications for obesity. Eli Lilly has …

pharmaceuticalcommerce.com

50%
OFF

Eli Lilly Now Offers Cheaper Single Dose Vials Of Zepbound For …

4 days from now

Aug 28, 2024 · Eli Lilly says the single-dose vials cost 50% less than other injectable GLP-1 weight loss drugs, providing expanded access to millions of people with obesity. On August …

healthnews.com

50%
OFF

Lilly Releases Zepbound® (tirzepatide) Single-dose Vials, Expanding ...

4 days from now

Aug 27, 2024 · Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity

stockhouse.com

50%
OFF

Lilly Releases Zepbound® (tirzepatide) Single-dose Vials, Expanding ...

4 days from now

Aug 27, 2024 · Distributed through LillyDirect®'s self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity

morningstar.com

$399
OFF

Lilly Launches Lower-price Weight Loss Drug Without Injector Pen

4 days from now

Aug 27, 2024 · A four-week supply of 2.5-milligram (mg) vials is $399, and a four-week supply of 5-mg vials is $529, less than half the list price of other GLP-1 medicines for obesity, according …

localnews8.com

FAQs about Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding ... Coupon?

Does lillydirect sell zepbound?

As of August 27, 2024, the Zepbound 2.5 and 5 mg vials are available via LillyDirect's self-pay pharmacy channel. 1, 2 Offering Zepbound single-dose vials in higher dosage strengths could increase the potential for dose-splitting, which is not contemplated by the FDA-approved label and may pose patient-safety risks. ...

What is zepbound & how does Eli Lilly work?

By making Zepbound more accessible and adaptable, Lilly is supporting healthcare providers in their mission to combat obesity on a larger scale. With the introduction of single-dose vials, Eli Lilly aims to provide healthcare professionals with greater flexibility and precision in dosing. ...

Will zepbound single-dose vials help patients with obesity?

"Outdated policies and lack of coverage for obesity medications create an urgent need for more innovative solutions. Bringing Zepbound single-dose vials to patients will help more people living with obesity manage this chronic condition. We will also continue to advocate for a system that better aligns with the science." ...

Can zepbound be used with other medications?

Zepbound contains tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if Zepbound is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products. It is not known if Zepbound can be used in people who have had pancreatitis. ...

What are the side effects of zepbound?

Common side effects The most common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn. These are not all the possible side effects of Zepbound. ...

Is zepbound a lifestyle choice?

“Despite obesity being recognized as a serious chronic illness with long-term consequences, it’s often misclassified as a lifestyle choice, resulting in many employers and the federal government excluding medications like Zepbound from insurance coverage,” Jonsson said. ...